OppenheimerFunds’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $12.8M | Hold |
500,000
| – | – | 0.02% | 636 |
|
|
2018
Q4 | $11.5M | Hold |
500,000
| – | – | 0.02% | 642 |
|
|
2018
Q3 | $16.1M | Hold |
500,000
| – | – | 0.02% | 640 |
|
|
2018
Q2 | $14.2M | Sell |
500,000
-1,368
| -0.3% | -$48.7K | 0.02% | 662 |
|
|
2018
Q1 | $17.7M | Buy |
501,368
+352
| +0.1% | +$14.1K | 0.02% | 595 |
|
|
2017
Q4 | $19.4M | Buy |
501,016
+808
| +0.2% | +$30.8K | 0.02% | 595 |
|
|
2017
Q3 | $12.7M | Sell |
500,208
-80
| -0% | -$1.95K | 0.02% | 704 |
|
|
2017
Q2 | $13.7M | Buy |
500,288
+131
| +0% | +$3.58K | 0.02% | 679 |
|
|
2017
Q1 | $16.6M | Buy |
500,157
+157
| +0% | +$4K | 0.02% | 636 |
|
|
2016
Q4 | $11.9M | Hold |
500,000
| – | – | 0.02% | 721 |
|
|
2016
Q3 | $18.4M | Hold |
500,000
| – | – | 0.02% | 598 |
|
|
2016
Q2 | $11.2M | Hold |
500,000
| – | – | 0.01% | 709 |
|
|
2016
Q1 | $10.4M | Hold |
500,000
| – | – | 0.01% | 718 |
|
|
2015
Q4 | $15.2M | Hold |
500,000
| – | – | 0.02% | 649 |
|
|
2015
Q3 | $12.3M | Hold |
500,000
| – | – | 0.02% | 675 |
|
|
2015
Q2 | $16.1M | Hold |
500,000
| – | – | 0.02% | 639 |
|
|
2015
Q1 | $17.9M | Hold |
500,000
| – | – | 0.02% | 620 |
|
|
2014
Q4 | $11.3M | Hold |
500,000
| – | – | 0.01% | 736 |
|
|
2014
Q3 | $9.7M | Hold |
500,000
| – | – | 0.01% | 745 |
|
|
2014
Q2 | $18.1M | Hold |
500,000
| – | – | 0.02% | 601 |
|
|
2014
Q1 | $19.4M | Hold |
500,000
| – | – | 0.02% | 578 |
|
|
2013
Q4 | $14.3M | Sell |
500,000
-100,000
| -17% | -$2.94M | 0.02% | 655 |
|
|
2013
Q3 | $21.5M | Hold |
600,000
| – | – | 0.03% | 515 |
|
|
2013
Q2 | $20M | Buy |
+600,000
| New | +$27.2M | 0.03% | 510 |
|
Other funds holding RIGL
TA
RSCM
